SPOKANE, Wash.--(BUSINESS WIRE)--Researchers at Signature Genomic Laboratories recently characterized 18 individuals with submicroscopic gains of DNA on chromosome 22 and suggest that duplication alone may not account for the clinical features in those individuals.
